In Vitro Diagnostic
Table of Contents
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing wi...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Robyn
+1 718 213 4904
Trellis Bioscience, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Trellis Bioscience, Inc. - Product Pipeline Review - 2013” provides data on the Trellis ...
Summary Bio-Rad Laboratories, Inc. (Bio-Rad) is a healthcare company. It undertakes the development and manufacture of specialty chemicals for use in biochemical, pharmaceutical and other life science ...
Summary Xhale, Inc. (Xhale) is a medical device company. The company develops non invasive medical devices for the diagnostic market. Its products include pharmaceutical supply chain integrity, therapeutic ...
... molecular diagnostic strategy. Over the last several months, we have announced two significant opportunities to commercialize innovative molecular diagnostics tests. These types of opportunities allow us ...
... En jap n, las ventas se elevaron un 1%. En el segundo trimestre de 2013, roche ha comunicado los planes para integrar el rea de negocio applied science en molecular diagnostics y professional ...
Reportlinker.com © Copyright 2013. All rights reserved.